BioPhy
Philadelphia, Pennsylvania, United States
Leveraging the possibilities of modern science and advanced technologies, BioPhy is committed to transforming the way promising drugs are identified and developed. With the help of its patent-pending predictive AI engine, BioPhy works to enhance the outcomes of clinical trials, reduce failure rates, and accelerate the pace of developing new drugs to improve the quality of healthcare outcomes across the globe. By integrating advanced probabilistic models, proprietary data, and geometric deep learning across the industry’s most advanced knowledge graph, we deliver unmatched predictive power and generative capabilities improving decision-making, productivity, and economics across the drug development lifecycle. Our technology updates it’s understanding of over 35,000 ongoing clinical trials every day and has been validated to predict trial outcomes in over 2,200+ studies over the past 3 years with over 80% accuracy, outperforming both human experts and other AI solutions.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2019
- Website
- www.biophy.ai/
Only accessible to MedStartr community members.
Join nowWhat do you think of BioPhy?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now